EICHORCondition: Diffuse Large B Cell Lymphoma · Sponsor: University College, London
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this trial is to compare the efficacy and safety of Inotuzumab Ozogamicin in combination with R-CVP with that of R-G-CVP for the treatment of Diffuse Large B Cell Lymphoma (DLBCL) in a population of patients not suitable for anthracycline based chemotherapy. There is no standard of care for the treatment of this group of patients. If demonstrated to be efficacious and safe to deliver this regimen will be further tested in a phase III trial to determine whether this should become the standard of care amongst patients with DLBCL not fit for anthracycline (R-CHOP).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Stoke Mandeville Hospital (including Wycombe Hospital) | Aylesbury, United Kingdom | — |
| North Hampshire Hospital | Basingstoke, United Kingdom | — |
| Royal United Hospital | Bath, United Kingdom | — |
| Royal Bournemouth Hospital | Bournemouth, United Kingdom | — |
| Bristol Oncology Centre | Bristol, United Kingdom | — |
| West Suffolk Hospital | Bury St Edmunds, United Kingdom | — |
| Kent and Canterbury Hospital | Canterbury, United Kingdom | — |
| Castle Hill Hospital | Cottingham, United Kingdom | — |
| University Hospital, Coventry | Coventry, United Kingdom | — |
| Darent Valley Hospital | Dartford, United Kingdom | — |
| Royal Devon & Exeter Hospital | Exeter, United Kingdom | — |
| Medway Maritime Hospital | Gillingham, United Kingdom | — |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01679119